Skip to main navigation Skip to search Skip to main content

Type I IFN signaling in CD8-DCs impairs Th1-dependent malaria immunity

  • Ashraful Haque*
  • , Shannon E. Best
  • , Marcela Montes De Oca
  • , Kylie R. James
  • , Anne Ammerdorffer
  • , Chelsea L. Edwards
  • , Fabian De Labastida Rivera
  • , Fiona H. Amante
  • , Patrick T. Bunn
  • , Meru Sheel
  • , Ismail Sebina
  • , Motoko Koyama
  • , Antiopi Varelias
  • , Paul J. Hertzog
  • , Ulrich Kalinke
  • , Sin Yee Gun
  • , Laurent Rénia
  • , Christiane Ruedl
  • , Kelli P.A. MacDonald
  • , Geoffrey R. Hill
  • Christian R. Engwerda
*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

87 Citations (Scopus)

Abstract

Many pathogens, including viruses, bacteria, and protozoan parasites, suppress cellular immune responses through activation of type I IFN signaling. Recent evidence suggests that immune suppression and susceptibility to the malaria parasite, Plasmodium, is mediated by type I IFN; however, it is unclear how type I IFN suppresses immunity to blood-stage Plasmodium parasites. During experimental severe malaria, CD4+ Th cell responses are suppressed, and conventional DC (cDC) function is curtailed through unknown mechanisms. Here, we tested the hypothesis that type I IFN signaling directly impairs cDC function during Plasmodium infection in mice. Using cDC-specific IFNAR1-deficient mice, and mixed BM chimeras, we found that type I IFN signaling directly affects cDC function, limiting the ability of cDCs to prime IFN-γ-producing Th1 cells. Although type I IFN signaling modulated all subsets of splenic cDCs, CD8- cDCs were especially susceptible, exhibiting reduced phagocytic and Th1-promoting properties in response to type I IFNs. Additionally, rapid and systemic IFN-α production in response to Plasmodium infection required type I IFN signaling in cDCs themselves, revealing their contribution to a feed-forward cytokine-signaling loop. Together, these data suggest abrogation of type I IFN signaling in CD8- splenic cDCs as an approach for enhancing Th1 responses against Plasmodium and other type I IFN-inducing pathogens.

Original languageEnglish
Pages (from-to)2483-2496
Number of pages14
JournalJournal of Clinical Investigation
Volume124
Issue number6
DOIs
Publication statusPublished - 2 Jun 2014
Externally publishedYes

Fingerprint

Dive into the research topics of 'Type I IFN signaling in CD8-DCs impairs Th1-dependent malaria immunity'. Together they form a unique fingerprint.

Cite this